Dose adjustment of clopidogrel in hyper-responder patients with unruptured intracranial aneurysms treated with stents.

Alejandro González Joaquin Ortega-Quintanilla Elena Zapata-Arriaza Asier de Albóniga-ChindurzaJose Raul García-LozanoMaría Isabel Luque VegaAurelio Cayuela

Published in: Journal of neurointerventional surgery (2019)

Reduction of the daily maintenance dose of clopidogrel in hyper-responder patients could provide a similar antiplatelet effect to the standard dose of clopidogrel, allowing a PRU value in the optimal range.

Keyphrases

acute coronary syndrome
percutaneous coronary intervention
antiplatelet therapy
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
coronary artery disease
atrial fibrillation
patient reported outcomes